Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Polymeric Systems for Cancer Immunotherapy: A Review
Thai Minh Duy Le, A‐Rum Yoon, Thavasyappan Thambi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 20

Showing 20 citing articles:

Polymer-Based Drug Delivery Systems for Cancer Therapeutics
Ling Ding, Prachi Agrawal, Sandeep Kumar Singh, et al.
Polymers (2024) Vol. 16, Iss. 6, pp. 843-843
Open Access | Times Cited: 24
Biomaterial-based platforms for modulating immune components against cancer and cancer stem cells
Nimeet Desai, Uzma Hasan, K Jeyashree, et al.
Acta Biomaterialia (2023) Vol. 161, pp. 1-36
Open Access | Times Cited: 24
Multifunctionality of cyclodextrin-based polymeric nanoparticulate delivery systems for chemotherapeutics, combination therapy, and theranostics
Lakshmi Sathi Devi, Cristina Casadidio, Maria Rosa Gigliobianco, et al.
International Journal of Pharmaceutics (2024) Vol. 654, pp. 123976-123976
Open Access | Times Cited: 13
Recent Findings on Therapeutic Cancer Vaccines: An Updated Review
Sara Sheikhlary, David Humberto Lopez, Sophia Moghimi, et al.
Biomolecules (2024) Vol. 14, Iss. 4, pp. 503-503
Open Access | Times Cited: 7
Clinical Application of Adenovirus (AdV): A Comprehensive Review
Md. Salauddin, Sukumar Saha, Md. Golzar Hossain, et al.
Viruses (2024) Vol. 16, Iss. 7, pp. 1094-1094
Open Access | Times Cited: 6
Production of Minor Ginsenoside CK from Major Ginsenosides by Biotransformation and Its Advances in Targeted Delivery to Tumor Tissues Using Nanoformulations
Mohanapriya Murugesan, Ramya Mathiyalagan, Vinothini Boopathi, et al.
Nanomaterials (2022) Vol. 12, Iss. 19, pp. 3427-3427
Open Access | Times Cited: 24
Atypical artificial cells: Novel biomimetic materials for combating cancer
Zhao‐yang Ren, Qianqian Wan, Yi‐na Zhu, et al.
Interdisciplinary materials (2024) Vol. 3, Iss. 5, pp. 658-714
Open Access | Times Cited: 4
Smart Accumulating Dual-Targeting Lipid Envelopes Equipping Oncolytic Adenovirus for Enhancing Cancer Gene Therapeutic Efficacy
Yuebin Zhao, Thai Minh Duy Le, JinWoo Hong, et al.
ACS Nano (2024)
Closed Access | Times Cited: 4
Hybrid polymeric scaffolds for brain applications: locoregional glioblastoma therapy
Riccardo Caraffi, Giulia Rovesti, Arianna Rinaldi, et al.
Elsevier eBooks (2025), pp. 315-358
Closed Access
Breaking barriers: Smart vaccine platforms for cancer immunomodulation
Mohammad Mahmoudi Gomari, Taha Ghantabpour, Nima Pourgholamamiji, et al.
Cancer Communications (2025)
Open Access
Immune checkpoint blocking in cancer therapy using thermosensitive hydrogels: a review
Vahid Tayebi-Khorrami, Mohammad Reza Fadaei, Shiva Fallahianshafiei, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Pharmacokinetic enhancement of oncolytic virus M1 by inhibiting JAK‒STAT pathway
Jingyi Tan, Jiayu Zhang, Cheng Hu, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 6, pp. 2554-2566
Open Access | Times Cited: 3
Synthesis and in vitro antitumor activity of galactosamine–docetaxel conjugates
Yongpeng Shen, Yi‐Lin Cheng, Haotian Hu, et al.
Chemical Biology & Drug Design (2024) Vol. 103, Iss. 3
Closed Access | Times Cited: 1
Improved Targeting of Therapeutics by Nanocarrier-Based Delivery in Cancer Immunotherapy and Their Future Perspectives
Anindita Dhara, Shourya Majumder, Srijoni Pahari, et al.
BioNanoScience (2023) Vol. 13, Iss. 1, pp. 278-299
Closed Access | Times Cited: 2
Polymer-mediated nanoformulations: a promising strategy for cancer immunotherapy
Simranjit Kaur, Adesh K. Saini, Hardeep Singh Tuli, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 3, pp. 1311-1326
Closed Access | Times Cited: 2
Advances and Challenges in Interventional Immuno-Oncology Locoregional Therapies
İzzet Altun, Yusuf Mert Demirlenk, Dila Atar, et al.
Journal of Vascular and Interventional Radiology (2024) Vol. 35, Iss. 2, pp. 164-172
Open Access
Nanotechnology as an emerging option in cancer immunotherapy
Manar Abdelhalem, Yousr Mahmoud Ibrahim, Habiba Mohamed Ibrahim, et al.
Elsevier eBooks (2024), pp. 37-70
Closed Access
Technological Strategies Applied to Pharmaceutical Systems for Intranasal Administration of Drugs Intended for Neurological Treatments: A Review
Maria Vitoria Gouveia Botan, Jéssica Bassi da Silva, Marcos Luciano Bruschi
AAPS PharmSciTech (2024) Vol. 25, Iss. 8
Closed Access
Polymeric Nanoparticles-Based Strategies for Cancer Immunotherapy
Ashish Kumar Parashar, Gaurav K. Saraogi, B. V. Tiwari, et al.
(2024), pp. 355-378
Closed Access
3D Centrifugation‐Enabled Priming of Synaptic Activation Promotes Primary T Cell Expansion
Ruoyu Jiang, Yu‐Hsi Chen, Ritesh Parajuli, et al.
Advanced Therapeutics (2023) Vol. 6, Iss. 12
Open Access | Times Cited: 1
3D Confinement-enabled Priming of Synaptic Activation Promotes Primary T Cell Expansion
Ruoyu Jiang, Yu‐Hsi Chen, Ritesh Parajuli, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top